Matti Nikkilä

862 total citations
22 papers, 712 citations indexed

About

Matti Nikkilä is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Matti Nikkilä has authored 22 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Immunology. Recurrent topics in Matti Nikkilä's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Matti Nikkilä is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Matti Nikkilä collaborates with scholars based in Finland. Matti Nikkilä's co-authors include Terho Lehtimäki, Timo Koivula, Hannu Jokela, Tiina Solakivi, Saara Lehtinen, Olli Jaakkola, Tero Sisto, Seppo Ylä‐Herttuala, T. Nikkari and Jukka Luoma and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology and Journal of the American Geriatrics Society.

In The Last Decade

Matti Nikkilä

22 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Nikkilä Finland 14 263 251 153 148 117 22 712
Elisa Campos United States 10 482 1.8× 401 1.6× 232 1.5× 55 0.4× 89 0.8× 16 778
P. Brizzi Italy 11 225 0.9× 255 1.0× 143 0.9× 44 0.3× 103 0.9× 17 732
Kee‐Sik Kim South Korea 16 135 0.5× 255 1.0× 503 3.3× 71 0.5× 94 0.8× 58 989
Tiina Solakivi Finland 20 396 1.5× 397 1.6× 349 2.3× 242 1.6× 157 1.3× 44 1.5k
A.J.H.H.M. van Oostrom Netherlands 13 251 1.0× 179 0.7× 440 2.9× 163 1.1× 236 2.0× 16 1.0k
Yuji Hirai Japan 16 198 0.8× 138 0.5× 252 1.6× 50 0.3× 167 1.4× 23 802
Pathmaja Paramsothy United States 13 304 1.2× 253 1.0× 200 1.3× 48 0.3× 196 1.7× 23 985
Ana Ninić Serbia 17 154 0.6× 163 0.6× 115 0.8× 118 0.8× 126 1.1× 58 714
Zhi Guo China 12 144 0.5× 107 0.4× 182 1.2× 127 0.9× 158 1.4× 24 874
Lars Eikvar Norway 15 108 0.4× 138 0.5× 162 1.1× 71 0.5× 56 0.5× 26 655

Countries citing papers authored by Matti Nikkilä

Since Specialization
Citations

This map shows the geographic impact of Matti Nikkilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Nikkilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Nikkilä more than expected).

Fields of papers citing papers by Matti Nikkilä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Nikkilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Nikkilä. The network helps show where Matti Nikkilä may publish in the future.

Co-authorship network of co-authors of Matti Nikkilä

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Nikkilä. A scholar is included among the top collaborators of Matti Nikkilä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Nikkilä. Matti Nikkilä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Päivä, Hannu, Juha Laakso, Inkeri Ruókonen, et al.. (2006). Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidation. Clinica Chimica Acta. 371(1-2). 97–101. 6 indexed citations
2.
Rontu, Riikka, Antti Hervonen, Sirkka Goebeler, et al.. (2006). Apolipoprotein E genotype is related to plasma levels of C‐reactive protein and lipids and to longevity in nonagenarians. Clinical Endocrinology. 64(3). 265–270. 43 indexed citations
3.
Rontu, Riikka, Saara Metso, Olli Jaakkola, et al.. (2005). Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 43(4). 357–60. 3 indexed citations
4.
Lehtimäki, Terho, Riikka Rontu, Sirkka Goebeler, et al.. (2005). Interleukin‐6 Modulates Plasma Cholesterol and C‐Reactive Protein Concentrations in Nonagenarians. Journal of the American Geriatrics Society. 53(9). 1552–1558. 19 indexed citations
5.
Päivä, Hannu, Terho Lehtimäki, Juha Laakso, et al.. (2004). Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia. Metabolism. 53(8). 1072–1075. 29 indexed citations
6.
7.
Lehtimäki, Terho, Saara Lehtinen, Tiina Solakivi, et al.. (1999). Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 19(1). 23–27. 162 indexed citations
8.
Saarelainen, Seppo, Terho Lehtimäki, Olli Jaakkola, et al.. (1999). Autoantibodies against Oxidised Low-Density Lipoprotein in Patients with Obstructive Sleep Apnoea. Clinical Chemistry and Laboratory Medicine (CCLM). 37(5). 517–520. 25 indexed citations
9.
Nikkilä, Matti, T Pitkäjärvi, Timo Koivula, et al.. (1996). Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis. 119(2). 181–190. 52 indexed citations
10.
Lehtinen, Saara, Terho Lehtimäki, Tero Sisto, et al.. (1995). Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 114(1). 83–91. 110 indexed citations
11.
12.
Nikkilä, Matti, et al.. (1991). Elevated high-density-lipoprotein cholesterol and normal triglycerides as markers of longevity. Journal of Molecular Medicine. 69(17). 780–785. 11 indexed citations
13.
Nikkilä, Matti, et al.. (1991). Once Daily Compared with Twice Daily Administration of Slow-Release Diltiazem as Monotherapy for Hypertension. Annals of Medicine. 23(2). 141–145. 2 indexed citations
14.
Nikkilä, Matti, et al.. (1990). Serum Cholesterol, High-density Lipoprotein Cholesterol and Five-year Survival in Elderly People. Age and Ageing. 19(6). 403–408. 25 indexed citations
15.
Nikkilä, Matti, et al.. (1990). High-Density Lipoprotein Cholesterol and Longevity. Age and Ageing. 19(2). 119–124. 46 indexed citations
16.
Nikkilä, Matti. (1989). Urinary Glycosaminoglycan Excretion in Normal and Stone-Forming Subjects: Significant Disturbance in Recurrent Stone Formers. Urologia Internationalis. 44(3). 157–159. 25 indexed citations
17.
Nikkilä, Matti, et al.. (1989). Serum Vitamin D Metabolite Concentrations in Primary Hyperparathyroidism. Annals of Medicine. 21(4). 281–283. 5 indexed citations
18.
Nikkilä, Matti, et al.. (1989). Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension. The American Journal of Cardiology. 63(17). 1227–1230. 14 indexed citations
19.
Nikkilä, Matti, Timo Koivula, & Hannu Jokela. (1989). Urinary Citrate Excretion in Patients with Urolithiasis andNormal Subjects. European Urology. 16(5). 382–385. 24 indexed citations
20.
Nikkilä, Matti & Amos Pasternack. (1988). Prevalence of Urolithiasis in a Finnish District. Scandinavian Journal of Urology and Nephrology. 22(4). 293–297. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Campos Breakdown of academic impact, for papers by P. Brizzi Breakdown of academic impact, for papers by Kee‐Sik Kim Breakdown of academic impact, for papers by Tiina Solakivi Breakdown of academic impact, for papers by A.J.H.H.M. van Oostrom Breakdown of academic impact, for papers by Yuji Hirai Breakdown of academic impact, for papers by Pathmaja Paramsothy Breakdown of academic impact, for papers by Ana Ninić Breakdown of academic impact, for papers by Zhi Guo Breakdown of academic impact, for papers by Lars Eikvar
Rankless by CCL
2026